Myriad Uranium to Conduct Minor Follow-On Financing
Myriad Uranium (OTCQB:MYRUF) has announced a follow-on non-brokered private placement financing to accommodate a key institutional investor. The company will issue 500,000 units at $0.25 per unit for gross proceeds of $125,000.
Each unit consists of one common share and one-half of one common share purchase warrant. Each full warrant allows the purchase of one share at $0.35 for 24 months from issuance. The securities will have a four-month hold period, and proceeds will be used for general working capital.
Myriad Uranium (OTCQB:MYRUF) ha annunciato un aumento di capitale non intermediato tramite una collocazione privata di follow-on per soddisfare le esigenze di un importante investitore istituzionale. La società emetterà 500.000 unità a 0,25 $ ciascuna, per un ricavo lordo complessivo di 125.000 $.
Ciascuna unità comprenderà una azione ordinaria e una metà di warrant per l'acquisto di azioni ordinarie. Ogni warrant intero darà diritto all'acquisto di una azione al prezzo di 0,35 $ entro 24 mesi dall'emissione. I titoli saranno soggetti a un periodo di lock-up di quattro mesi e i proventi verranno utilizzati per il capitale circolante generale.
Myriad Uranium (OTCQB:MYRUF) ha anunciado una colocación privada de seguimiento no intermediada para acomodar a un inversor institucional clave. La compañía emitirá 500.000 unidades a 0,25 $ por unidad, por unos ingresos brutos de 125.000 $.
Cada unidad estará compuesta por una acción ordinaria y media cobertura de warrant de compra de acciones ordinarias. Cada warrant completo permitirá la compra de una acción a 0,35 $ durante 24 meses desde su emisión. Los valores tendrán un periodo de retención de cuatro meses y los ingresos se destinarán a capital de trabajo general.
Myriad Uranium (OTCQB:MYRUF)는 주요 기관 투자자를 수용하기 위해 비중개형 후속 사모 방식의 자금 조달을 발표했습니다. 회사는 단가 0.25달러로 500,000유닛을 발행하여 총 125,000달러의 총수익을 확보할 예정입니다.
각 유닛은 보통주 1주와 보통주 매수 워런트 1/2을 포함합니다. 워런트 1매당 보통주 1주를 발행일로부터 24개월 이내에 0.35달러에 매수할 수 있는 권리가 부여됩니다. 해당 증권은 4개월의 보유기간이 적용되며, 수익금은 일반 운전자본으로 사용됩니다.
Myriad Uranium (OTCQB:MYRUF) a annoncé un placement privé de suivi non intermédié afin d'accueillir un investisseur institutionnel clé. La société émettra 500 000 unités à 0,25 $ l'unité, pour un produit brut de 125 000 $.
Chaque unité comprend une action ordinaire et une demi-warrant d'achat d'action ordinaire. Chaque warrant entier permettra l'achat d'une action au prix de 0,35 $ pendant 24 mois à compter de l'émission. Les titres seront soumis à une période de blocage de quatre mois et les fonds seront utilisés pour le fonds de roulement général.
Myriad Uranium (OTCQB:MYRUF) hat eine nicht vermittelte Folge-Privatplatzierung angekündigt, um einem wichtigen institutionellen Anleger entgegenzukommen. Das Unternehmen wird 500.000 Einheiten zu je 0,25 $ ausgeben und damit Bruttoerlöse von 125.000 $ erzielen.
Jede Einheit besteht aus einer Stammaktie und einer halben Stammaktien-Kaufoption (Warrant). Jeder volle Warrant berechtigt zum Kauf einer Aktie zum Preis von 0,35 $ innerhalb von 24 Monaten nach Ausgabe. Die Wertpapiere unterliegen einer Viermonats-Sperrfrist, und die Erlöse werden als allgemeines Betriebskapital verwendet.
- Secured interest from a key institutional investor
- Maintains consistent unit pricing with previous financing round
- Small financing amount of only $125,000 indicates limited capital raise
- Dilutive effect on existing shareholders
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Myriad Uranium Corp. (CSE: M) (OTCQB: MYRUF) (FSE: C3Q) ("Myriad" or the "Company") is pleased to announce that it will conduct a follow-on non-brokered private placement financing (the "Financing") on the same terms as its recently closed financing (see Myriad's news release dated July 11, 2025). Under the Financing, the Company will issue 500,000 units (each, a "Unit") at
The Company is conducting the Financing to accommodate the investment requirements of a key institutional investor. Securities issued under the Financing will be subject to a four month hold period in accordance with applicable Canadian securities laws. The Company intends to use the proceeds of the Financing for general working capital.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described in this news release in the United States. Such securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws, and, accordingly, may not be offered or sold within the United States, or to or for the account or benefit of persons in the United States or "U.S. Persons", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from such registration requirements.
About Myriad Uranium Corp.
Myriad Uranium Corp. is a uranium exploration company with an earnable
Myriad also has a
Myriad Contacts:
Thomas Lamb
President and CEO
tlamb@myriaduranium.com
Forward-Looking Statements
This news release contains "forward-looking information" that is based on the Company's current expectations, estimates, forecasts and projections. This forward-looking information includes, among other things, the Company's business, plans, outlook and business strategy. The words "may", "would", "could", "should", "will", "likely", "expect," "anticipate," "intend", "estimate", "plan", "forecast", "project" and "believe" or other similar words and phrases are intended to identify forward-looking information. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect, including with respect to the Company's business plans respecting the exploration and development of the Company's mineral properties, the proposed work program on the Company's mineral properties and the potential and economic viability of the Company's mineral properties. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the Company's actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include, but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative, environmental and other judicial, regulatory, political and competitive developments; and technological or operational difficulties. This list is not exhaustive of the factors that may affect our forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. The Company does not intend, and expressly disclaims any intention or obligation to, update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the contents of this news release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263198
FAQ
What is the size and price of Myriad Uranium's (MYRUF) latest financing round?
What are the warrant terms in Myriad Uranium's August 2025 private placement?
How will Myriad Uranium (MYRUF) use the proceeds from the August 2025 financing?
What is the hold period for securities issued in Myriad Uranium's latest financing?
